Journal Home
Search for

Volume 34, Issue 11, Pages 1834-1841 (November 2008)


View previous. 19 of 47 View next.

Effect of phacoemulsification on intraocular pressure in eyes with pseudoexfoliation: Single-surgeon series

Bradford J. Shingleton, MDCorresponding Author Informationemail address, Anupam Laul, OD, Karina Nagao, MD, Brian Wolff, OD, Mark O'Donoghue, OD, Edward Eagan, MD, Nancy Flattem, MD, Sonalee Desai-Bartoli, MD

Accepted 28 July 2008.

Purpose

To assess the effect of phacoemulsification with posterior chamber intraocular lens (IOL) implantation performed by a single surgeon on intraocular pressure (IOP) and glaucoma medication requirements in pseudoexfoliation (PFX) eyes with or without glaucoma.

Setting

Private practice, Boston, Massachusetts, USA.

Methods

This retrospective analysis comprised 1122 eyes with PFX having uneventful phacoemulsification with IOL implantation. Of the eyes, 882 did not have glaucoma (PFX group) and 240 had glaucoma (PXG group). A comparative outcomes analysis was performed; the analysis focused on IOP and change in glaucoma medication requirements between the 2 groups.

Results

The mean IOP was statistically significantly reduced through 7 years postoperatively compared with preoperatively in the PFX group. The PXG group had reduced mean IOP for 1 year and reduced glaucoma medication requirements at almost all postoperative time intervals. Higher mean preoperative IOP was associated with a greater reduction in mean IOP postoperatively in both groups. Intraocular pressure spikes (>30 mm Hg) 1 day postoperatively occurred in 4% in the PFX group and 17% in the PXG group. Postoperatively, 2.7% of PFX eyes progressed to a need for glaucoma medication and 3.7% of PXG eyes progressed to a need for laser and/or glaucoma surgery.

Conclusions

A long-term reduction in mean IOP occurred in PFX eyes with and without glaucoma. The IOP reduction was proportional to the preoperative IOP; higher preoperative IOP was associated with a greater reduction in IOP. Glaucoma progression in both groups was low, suggesting a protective effect of phacoemulsification on IOP in these eyes.

From a private practice, Boston, Massachusetts, USA

Corresponding Author InformationCorresponding author: Bradford J. Shingleton, MD, Center for Eye Research and Education, 50 Staniford Street, Suite 600, Boston, Massachusetts 02114, USA.

 No author has a financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(08)00833-X

doi:10.1016/j.jcrs.2008.07.025


View previous. 19 of 47 View next.